vs
Evolent Health, Inc.（EVH）与RBC Bearings INC（RBC）财务数据对比。点击上方公司名可切换其他公司
Evolent Health, Inc.的季度营收约是RBC Bearings INC的1.0倍（$468.7M vs $461.6M），RBC Bearings INC净利率更高（14.6% vs -91.6%，领先106.2%），RBC Bearings INC同比增速更快（17.0% vs -27.5%），过去两年RBC Bearings INC的营收复合增速更高（5.6% vs -14.4%）
马奎尔健康是一家美国营利性医疗管理企业，目前为森特里奇旗下子公司，核心服务对象为特殊群体，业务聚焦医疗领域多个细分赛道。客户群体涵盖健康保险计划、其他管理式医疗机构、企业、工会、各类军事与政府机构以及第三方管理机构，2021年位列财富美国500强第390名。
该文本实际介绍的并非RBC Bearings，而是美国多佛公司。多佛是一家工业产品综合制造商，1955年成立，总部位于伊利诺伊州当纳斯格罗夫。2021年其业务分为五大板块：工程产品、清洁能源与加注、成像与识别、泵与工艺解决方案、气候与可持续技术，是标普500成分股，在纽约证券交易所上市。
EVH vs RBC — 直观对比
营收规模更大
EVH
是对方的1.0倍
$461.6M
营收增速更快
RBC
高出44.5%
-27.5%
净利率更高
RBC
高出106.2%
-91.6%
两年增速更快
RBC
近两年复合增速
-14.4%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $468.7M | $461.6M |
| 净利润 | $-429.1M | $67.4M |
| 毛利率 | 20.7% | 44.3% |
| 营业利润率 | -87.1% | 22.3% |
| 净利率 | -91.6% | 14.6% |
| 营收同比 | -27.5% | 17.0% |
| 净利润同比 | -1782.0% | 16.4% |
| 每股收益（稀释后） | $-3.76 | $2.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EVHRBC
| Q4 25 | $468.7M | $461.6M | ||
| Q3 25 | $479.5M | $455.3M | ||
| Q2 25 | $444.3M | $436.0M | ||
| Q1 25 | $483.6M | $437.7M | ||
| Q4 24 | $646.5M | $394.4M | ||
| Q3 24 | $621.4M | $397.9M | ||
| Q2 24 | $647.1M | $406.3M | ||
| Q1 24 | $639.7M | $413.7M |
净利润EVHRBC
| Q4 25 | $-429.1M | $67.4M | ||
| Q3 25 | $-20.9M | $60.0M | ||
| Q2 25 | $-19.9M | $68.5M | ||
| Q1 25 | $-64.6M | $72.7M | ||
| Q4 24 | $-22.8M | $57.9M | ||
| Q3 24 | $-23.1M | $54.2M | ||
| Q2 24 | $1.6M | $61.4M | ||
| Q1 24 | $-17.3M | — |
毛利率EVHRBC
| Q4 25 | 20.7% | 44.3% | ||
| Q3 25 | 20.8% | 44.1% | ||
| Q2 25 | 22.6% | 44.8% | ||
| Q1 25 | 21.2% | 44.2% | ||
| Q4 24 | 11.7% | 44.3% | ||
| Q3 24 | 13.0% | 43.7% | ||
| Q2 24 | 16.5% | 45.3% | ||
| Q1 24 | 16.3% | 43.1% |
营业利润率EVHRBC
| Q4 25 | -87.1% | 22.3% | ||
| Q3 25 | 0.2% | 21.5% | ||
| Q2 25 | -0.3% | 23.2% | ||
| Q1 25 | -0.3% | 23.0% | ||
| Q4 24 | -2.9% | 21.7% | ||
| Q3 24 | -2.6% | 21.6% | ||
| Q2 24 | 1.2% | 24.0% | ||
| Q1 24 | -2.1% | 22.8% |
净利率EVHRBC
| Q4 25 | -91.6% | 14.6% | ||
| Q3 25 | -4.4% | 13.2% | ||
| Q2 25 | -4.5% | 15.7% | ||
| Q1 25 | -13.4% | 16.6% | ||
| Q4 24 | -3.5% | 14.7% | ||
| Q3 24 | -3.7% | 13.6% | ||
| Q2 24 | 0.2% | 15.1% | ||
| Q1 24 | -2.7% | — |
每股收益（稀释后）EVHRBC
| Q4 25 | $-3.76 | $2.13 | ||
| Q3 25 | $-0.24 | $1.90 | ||
| Q2 25 | $-0.44 | $2.17 | ||
| Q1 25 | $-0.63 | $2.33 | ||
| Q4 24 | $-0.26 | $1.82 | ||
| Q3 24 | $-0.27 | $1.65 | ||
| Q2 24 | $-0.06 | $1.90 | ||
| Q1 24 | $-0.22 | $1.92 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $151.9M | $107.6M |
| 总债务越低越好 | — | $990.2M |
| 股东权益账面价值 | $415.2M | $3.3B |
| 总资产 | $1.9B | $5.1B |
| 负债/权益比越低杠杆越低 | — | 0.30× |
8季度趋势，按日历期对齐
现金及短期投资EVHRBC
| Q4 25 | $151.9M | $107.6M | ||
| Q3 25 | $116.7M | $91.2M | ||
| Q2 25 | $151.0M | $132.9M | ||
| Q1 25 | $246.5M | $36.8M | ||
| Q4 24 | $104.2M | — | ||
| Q3 24 | $96.6M | — | ||
| Q2 24 | $101.3M | $76.8M | ||
| Q1 24 | $165.1M | $63.5M |
总债务EVHRBC
| Q4 25 | — | $990.2M | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $915.6M | ||
| Q1 25 | — | $920.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $1.2B |
股东权益EVHRBC
| Q4 25 | $415.2M | $3.3B | ||
| Q3 25 | $842.2M | $3.2B | ||
| Q2 25 | $896.0M | $3.1B | ||
| Q1 25 | $935.5M | $3.0B | ||
| Q4 24 | $1.0B | $2.9B | ||
| Q3 24 | $1.0B | $2.9B | ||
| Q2 24 | $1.1B | $2.8B | ||
| Q1 24 | $1.0B | $2.8B |
总资产EVHRBC
| Q4 25 | $1.9B | $5.1B | ||
| Q3 25 | $2.5B | $5.1B | ||
| Q2 25 | $2.5B | $4.8B | ||
| Q1 25 | $2.7B | $4.7B | ||
| Q4 24 | $2.5B | $4.7B | ||
| Q3 24 | $2.5B | $4.7B | ||
| Q2 24 | $2.5B | $4.7B | ||
| Q1 24 | $2.6B | $4.7B |
负债/权益比EVHRBC
| Q4 25 | — | 0.30× | ||
| Q3 25 | — | 0.34× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.30× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.43× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $48.8M | $122.1M |
| 自由现金流经营现金流 - 资本支出 | — | $99.1M |
| 自由现金流率自由现金流/营收 | — | 21.5% |
| 资本支出强度资本支出/营收 | — | 5.0% |
| 现金转化率经营现金流/净利润 | — | 1.81× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流EVHRBC
| Q4 25 | $48.8M | $122.1M | ||
| Q3 25 | $15.8M | $88.4M | ||
| Q2 25 | $-30.3M | $120.0M | ||
| Q1 25 | $4.6M | — | ||
| Q4 24 | $-26.2M | $84.0M | ||
| Q3 24 | $18.7M | — | ||
| Q2 24 | $21.4M | $97.4M | ||
| Q1 24 | $4.9M | — |
自由现金流EVHRBC
| Q4 25 | — | $99.1M | ||
| Q3 25 | — | $71.7M | ||
| Q2 25 | — | $104.3M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $73.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $88.4M | ||
| Q1 24 | — | — |
自由现金流率EVHRBC
| Q4 25 | — | 21.5% | ||
| Q3 25 | — | 15.7% | ||
| Q2 25 | — | 23.9% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 18.7% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 21.8% | ||
| Q1 24 | — | — |
资本支出强度EVHRBC
| Q4 25 | — | 5.0% | ||
| Q3 25 | — | 3.7% | ||
| Q2 25 | — | 3.6% | ||
| Q1 25 | — | 3.2% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | — | 4.1% | ||
| Q2 24 | — | 2.2% | ||
| Q1 24 | — | — |
现金转化率EVHRBC
| Q4 25 | — | 1.81× | ||
| Q3 25 | — | 1.47× | ||
| Q2 25 | — | 1.75× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.45× | ||
| Q3 24 | — | — | ||
| Q2 24 | 13.42× | 1.59× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EVH
| Commercial And Other Customers | $147.9M | 32% |
| Medicare Customers | $111.2M | 24% |
| Specialty Technology And Services Suite | $95.7M | 20% |
| Administrative Service | $55.8M | 12% |
| Cases | $47.7M | 10% |
| Related Party | $4.5M | 1% |
RBC
| Domestic | $413.3M | 90% |
| Foreign | $48.3M | 10% |
